193 related articles for article (PubMed ID: 12124799)
1. Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer.
Nagatsuka I; Yamada N; Shimizu S; Ohira M; Nishino H; Seki S; Hirakawa K
Int J Cancer; 2002 Aug; 100(5):515-9. PubMed ID: 12124799
[TBL] [Abstract][Full Text] [Related]
2. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.
Tomozawa S; Nagawa H; Tsuno N; Hatano K; Osada T; Kitayama J; Sunami E; Nita ME; Ishihara S; Yano H; Tsuruo T; Shibata Y; Muto T
Br J Cancer; 1999 Dec; 81(8):1274-9. PubMed ID: 10604722
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment with selective cyclooxygenase-2 inhibitor and fluorinated pyrimidines for liver metastasis of colon cancer.
Matsunaga N; Yamada N; Ohira M; Tachimori A; Nishiguchi Y; Nishino H; Seki S; Hirakawa K
Oncol Rep; 2004 Jan; 11(1):167-71. PubMed ID: 14654921
[TBL] [Abstract][Full Text] [Related]
5. JTE-522, a selective cyclooxygenase-2 inhibitor, inhibits induction but not growth and invasion of 1,2-dimethylhydrazine-induced tubular adenocarcinomas of colon in rats.
Wei M; Morimura K; Wanibuchi H; Shen J; Salim EI; Moku M; Hakoi K; Fukushima S
Int J Cancer; 2005 Jan; 113(3):354-8. PubMed ID: 15455344
[TBL] [Abstract][Full Text] [Related]
6. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines.
Uefuji K; Ichikura T; Shinomiya N; Mochizuki H
Anticancer Res; 2000; 20(6B):4279-84. PubMed ID: 11205258
[TBL] [Abstract][Full Text] [Related]
8. Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents.
Hida T; Kozaki K; Ito H; Miyaishi O; Tatematsu Y; Suzuki T; Matsuo K; Sugiura T; Ogawa M; Takahashi T; Takahashi T
Clin Cancer Res; 2002 Jul; 8(7):2443-7. PubMed ID: 12114451
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of beta1 integrin.
Yazawa K; Tsuno NH; Kitayama J; Kawai K; Okaji Y; Asakage M; Sunami E; Kaisaki S; Hori N; Watanabe T; Takahashi K; Nagawa H
Cancer Sci; 2005 Feb; 96(2):93-9. PubMed ID: 15723653
[TBL] [Abstract][Full Text] [Related]
10. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac.
Chen WS; Wei SJ; Liu JM; Hsiao M; Kou-Lin J; Yang WK
Int J Cancer; 2001 Mar; 91(6):894-9. PubMed ID: 11275997
[TBL] [Abstract][Full Text] [Related]
11. Selective cyclooxygenase-2 inhibitor downregulates the paracrine epithelial-mesenchymal interactions of growth in scirrhous gastric carcinoma.
Yashiro M; Nakazawa K; Tendo M; Kosaka K; Shinto O; Hirakawa K
Int J Cancer; 2007 Feb; 120(3):686-93. PubMed ID: 17096355
[TBL] [Abstract][Full Text] [Related]
12. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor.
Li Z; Shimada Y; Kawabe A; Sato F; Maeda M; Komoto I; Hong T; Ding Y; Kaganoi J; Imamura M
Carcinogenesis; 2001 Apr; 22(4):547-51. PubMed ID: 11285187
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.
Yao M; Lam EC; Kelly CR; Zhou W; Wolfe MM
Br J Cancer; 2004 Feb; 90(3):712-9. PubMed ID: 14760389
[TBL] [Abstract][Full Text] [Related]
14. JTE-522, a selective COX-2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: a vascular cast model study.
Kobayashi H; Gonda T; Uetake H; Higuchi T; Enomoto M; Sugihara K
Int J Cancer; 2004 Dec; 112(6):920-6. PubMed ID: 15386343
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
16. A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells.
Nishimura G; Yanoma S; Mizuno H; Kawakami K; Tsukuda M
Jpn J Cancer Res; 1999 Oct; 90(10):1152-62. PubMed ID: 10595745
[TBL] [Abstract][Full Text] [Related]
17. Profile of JTE-522 as a human cyclooxygenase-2 inhibitor.
Wakitani K; Nanayama T; Masaki M; Matsushita M
Jpn J Pharmacol; 1998 Nov; 78(3):365-71. PubMed ID: 9869271
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells.
Tendo M; Yashiro M; Nakazawa K; Yamada N; Hirakawa K
Cancer Sci; 2005 Jul; 96(7):451-5. PubMed ID: 16053517
[TBL] [Abstract][Full Text] [Related]
19. JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells.
Li HL; Zhang HW; Chen DD; Zhong L; Ren XD; St-Tu R
Acta Pharmacol Sin; 2002 Jul; 23(7):631-7. PubMed ID: 12100758
[TBL] [Abstract][Full Text] [Related]
20. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
Calviello G; Di Nicuolo F; Gragnoli S; Piccioni E; Serini S; Maggiano N; Tringali G; Navarra P; Ranelletti FO; Palozza P
Carcinogenesis; 2004 Dec; 25(12):2303-10. PubMed ID: 15358633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
